Results-oriented, hands-on large clinical trial experience in cardiovascular devices and medications; one and half year Chief Medical Officer in an International hospital in China, more than ten years invasive/interventional cardiologist and five years Director of Coronary Care Unit (CCU) in one of the first-class hospitals in China; more than ten years preclinical research experience in the field of cardiovascular disease in US well-known university medical centers; excellent record for professional career evidenced by grants from American Heart Association (AHA) and National Natural Science Foundation of China (NNSFC), more than 25 publications in peer-viewed medical journals, consultant or viewer for several peer-viewed cardiovascular journals, AHA appointed supervisor for international cardiologist etc.; more than five years cardiovascular laboratory manager.

COMPANY	POSITION HELD	DATES WORKED
(Confidential)	(Confidential)	3/2005 - Present
Sarver Heart Center, University of Arizona	(Confidential)	3/2003 - 2/2005
Cardiology, University of Minnesota	(Confidential)	2/2002 - 2/2003
Cardiology, Changhai Hospital, Second Molitary Medical University	(Confidential)	1/2001 - 1/2002
Cardiology, Cornell University Medical College	(Confidential)	1/2000 - 12/2000
Sarver Heart Center, University of Arizona	(Confidential)	2/1998 - 12/1999
Cardiology, Changhai Hospital, Second Military Medical University	(Confidential)	7/1995 - 1/1998
Cardiology, Wuhan General Hospital	(Confidential)	8/1989 - 8/1992
Wuhan General Hospital	(Confidential)	8/1983 - 8/1986

SCHOOL	MAJOR	YEAR	DEGREE
Second Military Medical University	Cardiology	1995	Doctorate Degree
Third Military Medical University	Cardiovascular Pathophysiology	1989	Master Degree
Tangshan Medical College	Medicine	1983	Medical Degree

Highlights:

Chief Medical Officer, United Family Hospitals & Clinics. Shanghai, China 09/2008 - present Research Assistant Professor/Research Scientist, University of Texas Medical Branch, Galveston, TX 03/2005 - 08/2008 Manager of cardiovascular lab, lead a 6-person group composed of research associate, postdoctoral fellow, residencies and medical students.? ? Pilot study on heart angiogenesis induced by moderate alcohol in rat (ongoing). Preclinical study on dilated cardiomyopathy caused by chronic high-dose alcohol consumption (ongoing).? Echocardiography and conductance catheter is used to estimate heart function in rat.? Cutting-edge molecular biological methods are used to study the mechanisms involved.Research Scientist, University Heart Center, University of Arizona, Tucson, AZ 03/2003 � 02/2005? Manager of cardiovascular lab, led a 5-person group.? Using the rat model developed by our lab in 1998 (chronic high-dose alcohol-feeding plus selenium-/vitamin E-deficient diet), we observed the heart changes from hypertrophy to dilation and cardiac dysfunction with echocardiography and conductance catheter. This is a novel animal model in this area (NIH founded).? Investigate the underlying molecular mechanisms with cutting-edge molecular biology methods..? Co- chaired �Practice of Medical Science� seminar series created to support the professional development of the postdoctoral scholars. Postdoctoral Fellow, Division of Cardiology, University of Minnesota, Minneaoplis, MN 02/2002 � 02/2003? ? Initiated a new research project on vascular endothelial cell dysfunction in redox factor-1 knock-out mice. This pilot study resulted in a grant ($75,000) founded by American Heart Association.Interventional Cardiologist, Associate Professor, Director of CCU, Division of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai, China 01/ 2001 � 01/2002? ? Interventional cardiology clinical work.? A leading cardiologist in charge of clinical trial �Clinical Observation of atorvastatin (lipitor) in Chinese people (phase IV)�.? A leading cardiologist in charge of clinical trial �Clinical observation of home-made ASD closure device in adult patients (phase I & II)�.? Consultant for Merck Pharmaceutical Company in Shanghai, China.? Mentor of three graduate students.? Preclinical study on angiogenesis in ischemic heart founded by National Natural Science Foundation of China (200,000 Yuan)Postdoctoral Fellow, Division of Cardiology, Cornell University Medical College, New York, NY 01/ 2000� 12/2000? Developed a novel murine model to study angiogenesis in aging and ischemic heart (murine auricular artery occlusion and neonatal heart transplantation to murine ear).? Mentored two graduate students for their research projects.Research Associate, University Heart Center, University of Arizona, Tucson, AZ 02/1998 � 12/1999? Developed an alcoholic cardiomyopathy rat model through chronic high-dose alcohol feeding plus selenium-deficient diet. This original study resulted in a grant ($200,000) founded by NIH.? ?Explored the possibility of using cultured cardiomyocytes to study mechanisms of alcoholic cardiomyopathy. This study was published at Journal of Cardiovascular Pharmacology.Interventional Cardiologist, Attending Physician, Associate Professor, Director of CCU, Division of Cardiology?Changhai Hospital, Second Military Medical University, Shanghai, China. 07/1995-01/1998? ??Interventional cardiology clinical work.? ??Mentored three graduate students for their research projects.? leading cardiologist in charge of clinical trial �Clinical observation of ?-blocker carvedilol in Chinese patients with congestive heart failure (phase IV)�? ?leading cardiologist in charge of clinical trial ?�Clinical observation of DF-521 (a kind of reptilase)� on AMI founded by a Japanese Pharmaceutical Company in Shanghai, China.Invasive Cardiologist, Attending Physician, Lecturer, Division of Cardiology, Wuhan General Hospital, Wuhan, China.07/1989-08/1992? ?General and invasive cardiology clinical work.? ??Mentored six residents.? ??Clinical observations of myocardial and cerebral ischemia in stroke patients.Residency, Department of Internal Medicine/Division of Cardiology, Wuhan General Hospital, Wuhan, China. 07/1983-08/1986? Rotation in general medicine.? ??Rotation in the Division of Cardiology.? ??Chief residency in the Department of Medicine.

Companies I like:

Abbott Laboratories, Medtronic, Novartis, Jhonson & Jhonson, Pfizer and other medical device companies and pharmaceutical companies.

P&L responsibilities
Presentation
Ecommerce Strategy and digital marketing channels optimization - SEO, SEM, email, affiliates - for high-profile accounts.
Technology Solutions
Sales Support
Software Implementation
Requirements Analysis & Specification
Leadership

• medical liaison
• scientist
• cardiovascular

1. Chief Medical Officer: in charge of daily medical & clinical work, assistant GM to set up regulations, deal with patients' complain. 2. Manager of cardiovascular lab, lead a 6-person group composed of research associate, postdoctoral fellow, residencies and medical students. 3. I do the research by myself including animal surgery, animal heart catheter procedures, echocardiography, molecular biology and histopathology studies, write the protocol, interprete results, write manuscript for publication and presentation, write grant proposal etc.